It suggests a new therapy in the field of immunotherapy and if i were to make an educated guess it likely is in the TCR-T category. "Professor Kristian Helin, chief executive of the ICR, said: “This new treatment is highly innovative because it finds a way to direct natural killer cells within the immune system to tumours without requiring complex and expensive re-engineering of a patient's own cells."
News 
Market Data 
Discover 
AI
